Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid

dc.date.accessioned	2020-10-21T06:45:15Z
dc.date.available	2020-10-21T06:45:15Z
dc.date.issued	2019
dc.date.issued	2019/04/27
dc.identifier.citation	Egeli U, Guney Eskiler G, Eryilmaz IE.J Pharm Pharmacol. 2019 Jul;71(7):1119-1132. doi: 10.1111/jphp.13097. Epub 2019 Apr 25.
dc.identifier.uri	http://doi.org/10.1111/jphp.13097
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71538
dc.description	PMID = 31025377
dc.relation.isversionof	10.1111/jphp.13097
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid
dc.type	article
dc.relation.journal	J Pharm Pharmacol
dc.identifier.doi	10.1111/jphp.13097
dc.contributor.author	Yurdacan B
dc.contributor.author	Egeli U
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Eryilmaz IE
dc.contributor.author	Cecener G
dc.contributor.author	Tunca B.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi